Concerns about potential pharma tariffs began before Trump took office after he repeatedly threatened a 25% tariff.

Merck joins a growing list of companies targeting lipoprotein(a), high levels of which are associated with an elevated risk ...

The pharmaceutical companies would say that the Inflation ... Adding Trump’s tariffs to the list would complicate the sector possibly more than others, with the tariffs acting as a “third ...